vs

Side-by-side financial comparison of Custom Truck One Source, Inc. (CTOS) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Custom Truck One Source, Inc. is the larger business by last-quarter revenue ($422.2M vs $225.6M, roughly 1.9× Organogenesis Holdings Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs -4.2%, a 23.6% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs -8.5%). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 14.8%).

Custom Truck One Source, Inc. is a leading provider of specialized heavy truck and equipment solutions in North America. It offers custom vehicle manufacturing, equipment sales and rentals, aftermarket parts, and maintenance services, serving core infrastructure, utility, construction, and energy industry segments.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

CTOS vs ORGO — Head-to-Head

Bigger by revenue
CTOS
CTOS
1.9× larger
CTOS
$422.2M
$225.6M
ORGO
Growing faster (revenue YoY)
ORGO
ORGO
+86.7% gap
ORGO
78.1%
-8.5%
CTOS
Higher net margin
ORGO
ORGO
23.6% more per $
ORGO
19.4%
-4.2%
CTOS
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
14.8%
CTOS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CTOS
CTOS
ORGO
ORGO
Revenue
$422.2M
$225.6M
Net Profit
$-17.8M
$43.7M
Gross Margin
20.3%
Operating Margin
2.9%
28.1%
Net Margin
-4.2%
19.4%
Revenue YoY
-8.5%
78.1%
Net Profit YoY
-333.7%
469.5%
EPS (diluted)
$-0.08
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTOS
CTOS
ORGO
ORGO
Q1 26
$422.2M
Q4 25
$387.3M
$225.6M
Q3 25
$359.9M
$150.9M
Q2 25
$392.2M
$101.0M
Q1 25
$307.1M
$86.7M
Q4 24
$398.3M
$126.7M
Q3 24
$337.5M
$115.2M
Q2 24
$320.6M
$130.2M
Net Profit
CTOS
CTOS
ORGO
ORGO
Q1 26
$-17.8M
Q4 25
$20.9M
$43.7M
Q3 25
$-5.8M
$21.6M
Q2 25
$-28.4M
$-9.4M
Q1 25
$-17.8M
$-18.8M
Q4 24
$27.6M
$7.7M
Q3 24
$-17.4M
$12.3M
Q2 24
$-24.5M
$-17.0M
Gross Margin
CTOS
CTOS
ORGO
ORGO
Q1 26
20.3%
Q4 25
31.8%
Q3 25
28.0%
Q2 25
26.1%
Q1 25
27.9%
72.6%
Q4 24
29.7%
75.5%
Q3 24
27.2%
76.7%
Q2 24
27.8%
77.6%
Operating Margin
CTOS
CTOS
ORGO
ORGO
Q1 26
2.9%
Q4 25
13.4%
28.1%
Q3 25
9.1%
13.7%
Q2 25
7.1%
-12.5%
Q1 25
4.0%
-30.9%
Q4 24
16.9%
8.1%
Q3 24
6.8%
5.4%
Q2 24
5.5%
-10.7%
Net Margin
CTOS
CTOS
ORGO
ORGO
Q1 26
-4.2%
Q4 25
5.4%
19.4%
Q3 25
-1.6%
14.3%
Q2 25
-7.2%
-9.3%
Q1 25
-5.8%
-21.7%
Q4 24
6.9%
6.1%
Q3 24
-5.2%
10.7%
Q2 24
-7.6%
-13.1%
EPS (diluted)
CTOS
CTOS
ORGO
ORGO
Q1 26
$-0.08
Q4 25
$0.10
$0.31
Q3 25
$-0.03
$0.11
Q2 25
$-0.13
$-0.10
Q1 25
$-0.08
$-0.17
Q4 24
$0.11
$0.05
Q3 24
$-0.07
$0.09
Q2 24
$-0.10
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTOS
CTOS
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$6.3M
$93.7M
Total DebtLower is stronger
$25.9M
Stockholders' EquityBook value
$809.1M
$300.1M
Total Assets
$3.4B
$598.7M
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTOS
CTOS
ORGO
ORGO
Q1 26
$6.3M
Q4 25
$6.3M
$93.7M
Q3 25
$13.1M
$63.7M
Q2 25
$5.3M
$73.1M
Q1 25
$5.4M
$110.0M
Q4 24
$3.8M
$135.6M
Q3 24
$8.4M
$94.3M
Q2 24
$8.1M
$89.9M
Total Debt
CTOS
CTOS
ORGO
ORGO
Q1 26
$25.9M
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.6B
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.6B
$62.3M
Q2 24
$1.5B
$63.8M
Stockholders' Equity
CTOS
CTOS
ORGO
ORGO
Q1 26
$809.1M
Q4 25
$809.1M
$300.1M
Q3 25
$784.7M
$255.1M
Q2 25
$790.1M
$233.2M
Q1 25
$813.4M
$242.9M
Q4 24
$861.3M
$262.9M
Q3 24
$837.5M
$278.5M
Q2 24
$856.7M
$263.5M
Total Assets
CTOS
CTOS
ORGO
ORGO
Q1 26
$3.4B
Q4 25
$3.4B
$598.7M
Q3 25
$3.5B
$509.8M
Q2 25
$3.6B
$461.1M
Q1 25
$3.5B
$467.4M
Q4 24
$3.5B
$497.9M
Q3 24
$3.6B
$446.3M
Q2 24
$3.5B
$443.2M
Debt / Equity
CTOS
CTOS
ORGO
ORGO
Q1 26
0.03×
Q4 25
2.03×
Q3 25
2.10×
Q2 25
2.04×
Q1 25
1.97×
Q4 24
1.77×
Q3 24
1.87×
0.22×
Q2 24
1.79×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTOS
CTOS
ORGO
ORGO
Operating Cash FlowLast quarter
$39.4M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTOS
CTOS
ORGO
ORGO
Q1 26
Q4 25
$47.3M
$39.4M
Q3 25
$81.5M
$3.1M
Q2 25
$125.7M
$-32.9M
Q1 25
$55.6M
$-19.9M
Q4 24
$82.1M
$10.9M
Q3 24
$16.5M
$8.7M
Q2 24
$37.8M
$4.7M
Free Cash Flow
CTOS
CTOS
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
CTOS
CTOS
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
CTOS
CTOS
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
CTOS
CTOS
ORGO
ORGO
Q1 26
Q4 25
2.27×
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
2.98×
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTOS
CTOS

Equipment sales$273.9M65%
Rental revenue$116.3M28%
Parts sales and services$32.1M8%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons